Pronutria Emerges From Stealth With $10.8 Million, Nutrients to Treat Disease

Published: Oct 22, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge's Pronutria on Tuesday unveiled details about its funding from founder Flagship Ventures and its plans to offer novel nutrient products that can treat diseases. Pronutria, formerly named Essentient, has been developing its products in stealth mode for two years after launching in the VentureLabs arm of Cambridge-based Flagship. The company disclosed Tuesday that it raised $10.8 million in Series A funding during that time.

Help employers find you! Check out all the jobs and post your resume.

Back to news